Terns Pharmaceuticals is based in Foster City, CA. It has raised $197M in total funding. Latest round: IPO.
Terns Pharmaceuticals funding overview
Terns Pharmaceuticals is based in Foster City, CA. Terns Pharmaceuticals has raised $197M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in February 2021. The round record for Terns Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Lilly Asia Ventures, OrbiMed Advisors, Vivo Capital. 3 distinct backers are named across the disclosed rounds.
Terns Pharmaceuticals at a glance
Total raised
$197M
Latest round
IPO
Latest round date
February 2021
Headquarters
Foster City, CA
Notable investors
Lilly Asia Ventures, OrbiMed Advisors, Vivo Capital
Frequently asked about Terns Pharmaceuticals funding
How much has Terns Pharmaceuticals raised?
Terns Pharmaceuticals has raised $197M in total disclosed funding across the rounds on record.
Who has invested in Terns Pharmaceuticals?
Lilly Asia Ventures, OrbiMed Advisors, Vivo Capital are named among the investors backing Terns Pharmaceuticals.
What was the latest Terns Pharmaceuticals funding round?
The most recent disclosed round is an IPO, announced in February 2021.
Where is Terns Pharmaceuticals based?
Terns Pharmaceuticals is based in Foster City, CA.
When did Terns Pharmaceuticals last raise?
The last disclosed Terns Pharmaceuticals round closed in February 2021 at IPO.
Round data for Terns Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Foster City and backer lists below.
